Thank you to our sponsors

Platinum Sponsor

At AstraZeneca Australia and New Zealand, we have been working to deliver life-changing medicines to patients for more than 60 years.

AstraZeneca is a global, science-led biopharmaceutical company engaged in the research, development, manufacture and supply of medicines that aim to make a real difference to the lives of Australians and New Zealanders. Our areas of focus include four therapy areas – Oncology; Cardiovascular, Renal and Metabolism (CVRM); and Respiratory and Immunology (R&I). 

We build our own capabilities by collaborating with world-renowned scientists, academic institutions, and like-minded, science-led companies.

Silver Sponsor

Servier is the Australian subsidiary of the global independent pharmaceutical company governed by a foundation.

For more than 40 years, Servier Australia has been a trusted partner in the treatment and management of hypertension in Australia.

As a company with deep expertise in this area, Servier is committed to working with healthcare professionals, patient organisations and policymakers to advance awareness, prevention and treatment. Servier is proud to partner with Hypertension Australia, Hypertension Task Force and the wider healthcare community in pursuit of a shared ambition: achieving 70% blood pressure control by 2030 to reduce the burden of cardiovascular disease.

Medtronic’s Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. 

In everything we do, we are engineering the extraordinary.

Medtronic is proud to partner with Hypertension Australia as platinum sponsors in 2024. As a leader in innovative medical technology, Medtronic is committed to transforming the treatment landscape for patients with hypertension. Medtronic aims to foster collaboration among clinicians, researchers, and industry stakeholders. Together, we can drive awareness and understanding of renal denervation’s potential to improve patient lives in Australia.

Meeting Supporter

Every day, millions of patients, caregivers, and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, hospital, and surgical products used across patient homes, every hospital department, physician offices and other sites of care. For over 90 years, Baxter has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen.

Baxter’s products, digital health solutions and therapies are available in more than 100 countries where Baxter employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

With the acquisition of Welch Allyn, Baxter now proudly supplies the Connex range of patient monitors, offering BP averaging technology for improved detection of hypertension, and enhancing patient care through advanced monitoring technology, ensuring timely and accurate vital signs measurements.

Tabletop Exhibitors

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,700 people in 80 countries and markets its products in around 170 countries.

Novo Nordisk has been operating in Australia since 1976. We deliver medicines to more than 1.6 million patients in Australia for the treatment of diabetes, obesity, rare diseases and other serious chronic diseases. For more information, visit www.novonordisk.com.au

Diasorin is committed to improving healthcare by providing an unparalleled portfolio of exclusive, high-quality immunoassays and fully automated chemiluminescence analyzers that deliver standardised and unbiased results. As easy-to-use as they are reliable, we allow laboratory and healthcare professionals to streamline their diagnostic pathways while ensuring complete harmonisation between urgent, specialty and routine tests.

Proudly Australian owned and part of DBG Health, Arrotex Pharmaceuticals is Australia’s largest and most diversified pharmaceutical company, offering the most extensive range of prescription medicines across therapeutic areas. We are committed to ensuring timely, sustainable, and affordable healthcare solutions that enhance patient outcomes and support healthcare providers. With unmatched expertise in pharmacy and healthcare, Arrotex continues to invest in Australia’s healthcare ecosystem, delivering trusted medicines, innovative programs, and strategic partnerships that create real value for patients, healthcare providers, and partners.